BG-75202

DRUG2 trials

Sponsors

BeOne Medicines

Conditions

Advanced Solid TumorBreast CancerMyeloid Malignancy

Phase 1

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

RecruitingNCT07222267

BeOne MedicinesAdvanced Solid Tumor, Breast Cancer

Start: 2025-12-11End: 2037-01-13Target: 86Updated: 2026-08-14

An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Patients With Myeloid Malignancies

RecruitingNCT07619287

BeOne MedicinesMyeloid Malignancy

Start: 2026-06-23End: 2028-09-30Target: 118Updated: 2026-09-14